WATSON PHARMACEUTICALS INC·4

Mar 2, 2:41 PM ET

WATSON PHARMACEUTICALS INC 4

4 · WATSON PHARMACEUTICALS INC · Filed Mar 2, 2005

Insider Transaction Report

Form 4
Period: 2005-02-28
AMATO LYNNE
VP, Brand Sales & Operations
Transactions
  • Exercise/Conversion

    Common Stock, par value $0.0033

    2005-02-28$21.25/sh+15,000$318,75015,057 total
  • Sale

    Common Stock, par value $0.0033

    2005-02-28$31.82/sh15,000$477,30057 total
  • Exercise/Conversion

    Incentive Stock Options to Purchase Common Stock

    2005-02-2815,0000 total
    Exercise: $21.25From: 2002-06-23Exp: 2007-06-23Common Stock, par value $0.0033 (15,000 underlying)

Documents

1 file
  • 4
    edgar.xmlPrimary

    FORM 4 -